Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma

Multiple myeloma (MM) has a five-year prevalence worldwide of 230,000 people and is known as the second most common hematological malignancy within the United States. Extensive research has been conducted to gain a wide range of treatment strategies, providing hope to these patients. Combination the...

Descripción completa

Detalles Bibliográficos
Autores principales: Padda, Jaskamal, Khalid, Khizer, Zubair, Ujala, Peethala, Mounika M, Kakani, Varsha, Goriparthi, Lakshmi, Almanie, Abdulelah H, Cooper, Ayden Charlene, Jean-Charles, Gutteridge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310625/
https://www.ncbi.nlm.nih.gov/pubmed/34322356
http://dx.doi.org/10.7759/cureus.15917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310625/
https://www.ncbi.nlm.nih.gov/pubmed/34322356
http://dx.doi.org/10.7759/cureus.15917

Ejemplares similares